Simulations Plus

Simulations Plus Intangible Assets

The Intangible Assets of Simulations Plus (SLP) as of Sep 27, 2026 is 29.21 M USD. In the previous year, Intangible Assets was 58.84 M USD — a change of -50.36% (lower).

Intangible Assets

29.21 MUSD

YoY

-50.36%

Last updated:

Intangible Assets of Simulations Plus is 2026 29.21 M USD. Intangible Assets of Simulations Plus was 2025 58.84 M USD. It decreases by -50.36% lower compared to the previous year.

The Simulations Plus Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
14.70 M USD
Jan 1, 2019
13.30 M USD
Jan 1, 2020
25.00 M USD
Jan 1, 2021
24.60 M USD
Jan 1, 2022
26.20 M USD
Jan 1, 2023
32.80 M USD
Jan 1, 2024
58.84 M USD
Jan 1, 2025
29.21 M USD
The Simulations Plus Intangible Assets history
YEARIntangible AssetsYoY
29.21 MUSD-50.36%
58.84 MUSD+79.39%
32.80 MUSD+25.19%
26.20 MUSD+6.50%
24.60 MUSD-1.60%
25.00 MUSD+87.97%
13.30 MUSD-9.52%
14.70 MUSD-2.65%
15.10 MUSD+51.00%
10.00 MUSD-5.66%
10.60 MUSD+13.98%
9.30 MUSD—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Intangible Assets of Simulations Plus is 29.21 M USD in 2026.

Intangible Assets of Simulations Plus changed from 58.84 M USD to 29.21 M USD, representing a -50.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Simulations Plus

All Key Metrics — Simulations Plus